Replies to post #119342 on Biotech Values

[mcbio]

I couldnt quite understand from the call if AZN will report at ASCO or not. could you figure it out from the call?

I believe that exact question was posed during Q&A and it was noted that AZN will not be presenting any Phase 2 data on Selumetinib at ASCO. ARRY re-iterated that they expected the data to be out this year and possibly as early as late this summer.